After completing this article, readers should be able to:
Understand the changes in epidemiology of pneumococcal infections after the introduction of pneumococcal conjugate vaccines.
Describe the clinical manifestations caused by Streptococcus pneumoniae and their empirical antibiotic therapy recommendations.
Identify children with underlying medical conditions at high risk for invasive pneumococcal disease and provide adequate pneumococcal vaccination.
Pediatrics in review / American Academy of Pediatrics
Olarte, L., Jackson, M. Streptococcus pneumoniae Pediatrics in review / American Academy of Pediatrics 42, 349-359 (2021).